Main navigation
|
 |
| |
HIV/AIDS |
Main content
|
Post-exposure prophylaxis
|
Post-exposure prophylaxis (PEP) is short-term antiretroviral treatment to reduce the likelihood of HIV infection after potential exposure, either occupationally or through sexual intercourse. Within the health sector, PEP should be provided as part of a comprehensive universal precautions package that reduces staff exposure to infectious hazards at work.
|
key publication
Post-exposure prophylaxis to prevent HIV infection
Guidelines created from a Joint WHO/ILO expert consultation on occupational and non-occupational HIV post-exposure prophylaxis held in Geneva in September 2005, are now available.
More information
Background
HIV post-exposure prophylaxis for occupational and non-occupational exposure to HIV infection
The use of ARVs for HIV post-exposure prophylaxis (HIV-PEP) following occupational exposure to HIV, and the recent expansion of HIV-PEP to non-occupational situations, have raised numerous areas of uncertainty for policy makers and healthcare providers caring for potentially exposed individuals. Key issues among these are the appropriate indications for HIV-PEP, ART choices, and management strategies to accompany use of PEP for HIV. With the expanding availability of ART in resource-poor settings, issues of provision of HIV-PEP require policy decision that can be implemented in programme and services delivery planning.
More information
Visit the antiretroviral treatment main page
|
|
|
|
|
|
